CAS 75626-12-9

4-phenyl-1,2,3,4-tetrahydroisoquinoline hydrochloride

Description:

4-Phenyl-1,2,3,4-tetrahydroisoquinoline hydrochloride is a chemical compound that belongs to the class of tetrahydroisoquinolines, which are bicyclic organic compounds. This substance is characterized by its bicyclic structure, featuring a phenyl group attached to the tetrahydroisoquinoline core. It typically appears as a white to off-white crystalline powder and is soluble in water and various organic solvents, which makes it useful in pharmaceutical applications. The hydrochloride salt form enhances its stability and solubility, facilitating its use in biological studies and potential therapeutic applications. This compound has garnered interest in medicinal chemistry due to its structural similarity to various bioactive molecules, suggesting potential pharmacological properties. Its synthesis often involves multi-step organic reactions, and it may be utilized in research related to neuropharmacology and other fields. As with many chemical substances, handling should be conducted with care, adhering to safety protocols to mitigate any risks associated with its use.

Formula: C₁₅H₁₆ClN

InChI: InChI=1/C15H15N.ClH/c1-2-6-12(7-3-1)15-11-16-10-13-8-4-5-9-14(13)15;/h1-9,15-16H,10-11H2;1H

SMILES: c1ccc(cc1)C1CNCc2ccccc12.Cl

Synonyms:

• 4-Phenyl-1,2,3,4-tetrahydroisoquinoline hydrochloride (1:1)

4-Phenyl-1,2,3,4-tetrahydroisoquinoline, HCl

CAS: 75626-12-9

Formula: C₁₅H₁₅N

Purity: 95%

Color and Shape: Solid

Molecular weight: 209.2863

Ref: IN-DA005JHA

4-Phenyl-1,2,3,4-tetrahydroisoquinoline HCl

CAS: 75626-12-9

4-Phenyl-1,2,3,4-tetrahydroisoquinoline HCl (4PTI) is a purgative drug that is used for the treatment of chronic kidney disease. It has been shown to have an inhibitory effect on cancer cells in culture. 4PTI prevents the uptake of glucose and fatty acids into the cell by binding to the cellular receptor for these substances. This binding inhibits cellular uptake of glucose and fatty acids by inhibiting the translocation of GLUT1 from intracellular compartments to the plasma membrane. 4PTI also blocks dopamine release from nerve terminals in rat striatum by inhibiting dopamine uptake.

Formula: C₁₅H₁₆ClN

Purity: Min. 95%

Molecular weight: 245.75 g/mol

Ref: 3D-ADA62612